Literature DB >> 17198224

Imaging for spine tumors and new applications.

Courtnay W Bloomer1, Andrew Ackerman, Rita G Bhatia.   

Abstract

OBJECTIVES: Discuss intramedullary, intradural/extramedullary, and extradural spinal tumors including imaging characteristics with emphasis on MR and advances in treatment.
METHODS: Literature and institutional review.
RESULTS: Spinal tumors: intramedullary, intradural/extramedullary, and extradural, comprise a wide range of histological tumors with an even wider range of clinical symptoms and prognostic features. They are relatively rare and if left untreated, can cause serious neurological deficits and disability. An accurate diagnosis is therefore crucial in determining prognosis and directing therapy. Magnetic resonance imaging (MRI) has revolutionized the diagnosis of intraspinal tumors, allowing for early detection and improved anatomical localization. Magnetic resonance has also become an integral part in staging of both primary and metastatic neoplasms of the spine for guiding therapy and is an excellent modality for follow-up. Advances in MRI (perfusion and molecular imaging) may help refine and describe these neoplasms for accurate treatment and prognosis in the future. Surveillance protocols and role of magnetic resonance are not well established.
CONCLUSIONS: Magnetic resonance plays an integral role in evaluation of spinal tumors with increasing role in staging and treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17198224     DOI: 10.1097/RMR.0b013e31802bb38f

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  15 in total

Review 1.  Intradural spinal tumors: current classification and MRI features.

Authors:  Kasim Abul-Kasim; Majda M Thurnher; Paul McKeever; Pia C Sundgren
Journal:  Neuroradiology       Date:  2007-12-15       Impact factor: 2.804

2.  Spinal inclusion cysts.

Authors:  Dominic N P Thompson
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

3.  Differentiation of localization of spinal hemangioblastomas based on imaging and pathological findings.

Authors:  Shiro Imagama; Zenya Ito; Norimitsu Wakao; Yoshihito Sakai; Fumihiko Kato; Yasutsugu Yukawa; Koji Sato; Kei Ando; Kenichi Hirano; Ryoji Tauchi; Akio Muramoto; Yoshio Hashizume; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Eur Spine J       Date:  2011-04-29       Impact factor: 3.134

4.  Characterization of magnetic resonance images for spinal cord tumors.

Authors:  Jae Yoon Chung; Jae Joon Lee; Hyun Jong Kim; Hyung Yeon Seo
Journal:  Asian Spine J       Date:  2008-06-30

5.  Spinal dual-energy computed tomography: improved visualisation of spinal tumorous growth with a noise-optimised advanced monoenergetic post-processing algorithm.

Authors:  Mareen Kraus; Jakob Weiss; Nadja Selo; Thomas Flohr; Mike Notohamiprodjo; Fabian Bamberg; Konstantin Nikolaou; Ahmed E Othman
Journal:  Neuroradiology       Date:  2016-08-11       Impact factor: 2.804

6.  Cervical intramedullary epidermoid cyst with liquid contents.

Authors:  Amit Agarwal; Arvind Bhake; Anand Kakani
Journal:  Asian Spine J       Date:  2011-03-02

7.  Mature teratoma of the spinal cord in adults: An unusual case.

Authors:  Yuan Li; Bo Yang; Laijun Song; Dongming Yan
Journal:  Oncol Lett       Date:  2013-08-08       Impact factor: 2.967

8.  Case study of a spinal epidural capillary hemangioma: a 4-year postoperative follow-up.

Authors:  Arsen Seferi; Ridvan Alimehmeti; Gentian Vyshka; Teona Bushati; Mentor Petrela
Journal:  Global Spine J       Date:  2013-08-22

9.  Surgery and outcomes of six patients with intradural epidermoid cysts in the lumbar spine.

Authors:  Huabin Yin; Dan Zhang; Zhipeng Wu; Wang Zhou; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2014-03-04       Impact factor: 2.754

10.  Magnetic resonance spectroscopy (MRS) of vertebral column - an additional tool for evaluation of aggressiveness of vertebral haemangioma like lesion.

Authors:  Miran Jeromel; Janez Podobnik
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.